Partnering T-VEC With a Targeted Agent for the Treatment of Melanoma

Igor Puzanov, MD

Special Reports, Melanoma (Issue 3), Volume 3, Issue 1

Igor Puzanov, MD, medical oncologist, Vanderbilt-Ingram Cancer Center, discusses the potential to partner T-VEC with a targeted agent for the treatment of patients with melanoma.

Igor Puzanov, MD, medical oncologist, Vanderbilt-Ingram Cancer Center, discusses the potential to partner T-VEC with a targeted agent for the treatment of patients with melanoma.

Learn about targeted agents for the treatment of melanoma > >